Characteristics of Asthma Exacerbations That Required Hospitalization in Patients with Severe, Uncontrolled Asthma Receiving Tezepelumab Compared with Placebo: Results from the Phase 3 NAVIGATOR Study

被引：0

作者：

Ambrose, C. S. ^{[1
]}

Cook, B. ^{[1
]}

Roseti, S. L. ^{[2
]}

Gelhorn, H. ^{[3
]}

Cutts, K. ^{[3
]}

Lindsley, A. W. ^{[4
]}

Colice, G. ^{[2
]}

机构：

[1] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA

[2] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Late Stage Dev, Gaithersburg, MD USA

[3] Evidera, Bethesda, MD USA

[4] Amgen Inc, US Med Affairs, Thousand Oaks, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A3420

引用

页数：2